Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Treasury Shares (2016 - 2025)

Historic Treasury Shares for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $4.3 billion.

  • United Therapeutics' Treasury Shares rose 2263.69% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year increase of 2263.69%. This contributed to the annual value of $3.5 billion for FY2024, which is 3471.23% up from last year.
  • Latest data reveals that United Therapeutics reported Treasury Shares of $32.8 million as of Q3 2025, which was up 874.68% from $30.2 million recorded in Q2 2025.
  • In the past 5 years, United Therapeutics' Treasury Shares registered a high of $32.8 million during Q3 2025, and its lowest value of $181772.0 during Q2 2024.
  • Over the past 5 years, United Therapeutics' median Treasury Shares value was $26.6 million (recorded in 2021), while the average stood at $26.5 million.
  • In the last 5 years, United Therapeutics' Treasury Shares changed by 0.0% in 2021 and then surged by 3474.33% in 2024.
  • Quarter analysis of 5 years shows United Therapeutics' Treasury Shares stood at $2.6 billion in 2021, then changed by 0.0% to $2.6 billion in 2022, then changed by 0.0% to $2.6 billion in 2023, then soared by 34.71% to $3.5 billion in 2024, then grew by 22.67% to $4.3 billion in 2025.
  • Its Treasury Shares was $4.3 billion in Q3 2025, compared to $3.5 billion in Q2 2025 and $3.5 billion in Q1 2025.